nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—hypertension—metabolic syndrome X	0.962	1	CtDrD
Nadolol—ADRB3—brown adipose tissue—metabolic syndrome X	0.0194	0.729	CbGeAlD
Nadolol—ADRB3—adipose tissue—metabolic syndrome X	0.00262	0.0983	CbGeAlD
Nadolol—Abdominal bloating—Metformin—metabolic syndrome X	0.00122	0.142	CcSEcCtD
Nadolol—ADRB1—cardiovascular system—metabolic syndrome X	0.00121	0.0456	CbGeAlD
Nadolol—ADRB1—adipose tissue—metabolic syndrome X	0.00107	0.0402	CbGeAlD
Nadolol—Respiratory distress—Metformin—metabolic syndrome X	0.000918	0.106	CcSEcCtD
Nadolol—ABCB1—blood vessel—metabolic syndrome X	0.000911	0.0342	CbGeAlD
Nadolol—Nasal congestion—Metformin—metabolic syndrome X	0.000465	0.0538	CcSEcCtD
Nadolol—Lethargy—Metformin—metabolic syndrome X	0.000432	0.05	CcSEcCtD
Nadolol—ABCB1—cardiovascular system—metabolic syndrome X	0.000407	0.0153	CbGeAlD
Nadolol—ABCB1—kidney—metabolic syndrome X	0.000398	0.0149	CbGeAlD
Nadolol—Abdominal distension—Metformin—metabolic syndrome X	0.000368	0.0427	CcSEcCtD
Nadolol—ABCB1—adipose tissue—metabolic syndrome X	0.000358	0.0135	CbGeAlD
Nadolol—Abdominal discomfort—Metformin—metabolic syndrome X	0.000351	0.0406	CcSEcCtD
Nadolol—Bradycardia—Metformin—metabolic syndrome X	0.000298	0.0345	CcSEcCtD
Nadolol—ABCB1—liver—metabolic syndrome X	0.000251	0.00945	CbGeAlD
Nadolol—Flatulence—Metformin—metabolic syndrome X	0.000251	0.0291	CcSEcCtD
Nadolol—Vision blurred—Metformin—metabolic syndrome X	0.00024	0.0278	CcSEcCtD
Nadolol—Syncope—Metformin—metabolic syndrome X	0.000229	0.0265	CcSEcCtD
Nadolol—Loss of consciousness—Metformin—metabolic syndrome X	0.000224	0.026	CcSEcCtD
Nadolol—Hypertension—Metformin—metabolic syndrome X	0.00022	0.0255	CcSEcCtD
Nadolol—Chest pain—Metformin—metabolic syndrome X	0.000217	0.0251	CcSEcCtD
Nadolol—Oedema—Metformin—metabolic syndrome X	0.000208	0.0241	CcSEcCtD
Nadolol—Shock—Metformin—metabolic syndrome X	0.000205	0.0237	CcSEcCtD
Nadolol—Hyperhidrosis—Metformin—metabolic syndrome X	0.000201	0.0233	CcSEcCtD
Nadolol—Anorexia—Metformin—metabolic syndrome X	0.000198	0.023	CcSEcCtD
Nadolol—Hypotension—Metformin—metabolic syndrome X	0.000194	0.0225	CcSEcCtD
Nadolol—Paraesthesia—Metformin—metabolic syndrome X	0.000187	0.0216	CcSEcCtD
Nadolol—Dyspnoea—Metformin—metabolic syndrome X	0.000185	0.0215	CcSEcCtD
Nadolol—Dyspepsia—Metformin—metabolic syndrome X	0.000183	0.0212	CcSEcCtD
Nadolol—Decreased appetite—Metformin—metabolic syndrome X	0.000181	0.0209	CcSEcCtD
Nadolol—Fatigue—Metformin—metabolic syndrome X	0.000179	0.0208	CcSEcCtD
Nadolol—Constipation—Metformin—metabolic syndrome X	0.000178	0.0206	CcSEcCtD
Nadolol—Asthenia—Metformin—metabolic syndrome X	0.000149	0.0173	CcSEcCtD
Nadolol—Pruritus—Metformin—metabolic syndrome X	0.000147	0.017	CcSEcCtD
Nadolol—Diarrhoea—Metformin—metabolic syndrome X	0.000142	0.0165	CcSEcCtD
Nadolol—Dizziness—Metformin—metabolic syndrome X	0.000138	0.0159	CcSEcCtD
Nadolol—Vomiting—Metformin—metabolic syndrome X	0.000132	0.0153	CcSEcCtD
Nadolol—Rash—Metformin—metabolic syndrome X	0.000131	0.0152	CcSEcCtD
Nadolol—Dermatitis—Metformin—metabolic syndrome X	0.000131	0.0152	CcSEcCtD
Nadolol—Nausea—Metformin—metabolic syndrome X	0.000124	0.0143	CcSEcCtD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	3.55e-05	0.0123	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—CNR1—metabolic syndrome X	3.32e-05	0.0115	CbGpPWpGaD
Nadolol—ADRB2—Arf6 trafficking events—INS—metabolic syndrome X	3.06e-05	0.0106	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	3.04e-05	0.0105	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—GCK—metabolic syndrome X	2.83e-05	0.00981	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	2.77e-05	0.00959	CbGpPWpGaD
Nadolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	2.6e-05	0.00899	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	2.48e-05	0.00861	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	2.37e-05	0.00821	CbGpPWpGaD
Nadolol—ABCB1—ABC-family proteins mediated transport—APOA1—metabolic syndrome X	2.33e-05	0.00806	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—MTNR1B—metabolic syndrome X	2.32e-05	0.00803	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	2.25e-05	0.00779	CbGpPWpGaD
Nadolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	2.15e-05	0.00743	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	2.13e-05	0.00737	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	2.11e-05	0.0073	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	2.06e-05	0.00714	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	1.81e-05	0.00626	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—HTR2C—metabolic syndrome X	1.8e-05	0.00625	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	1.77e-05	0.00612	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—GHRL—metabolic syndrome X	1.71e-05	0.00593	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	1.65e-05	0.00571	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	1.64e-05	0.00569	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CNR1—metabolic syndrome X	1.62e-05	0.00561	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	1.61e-05	0.00557	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	1.47e-05	0.00511	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—LEP—metabolic syndrome X	1.45e-05	0.00502	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	1.44e-05	0.005	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	1.41e-05	0.00487	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	1.38e-05	0.00478	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	1.38e-05	0.00477	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—MTNR1B—metabolic syndrome X	1.37e-05	0.00476	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—MTNR1B—metabolic syndrome X	1.35e-05	0.00466	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	1.33e-05	0.00462	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—MTNR1B—metabolic syndrome X	1.31e-05	0.00454	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	1.3e-05	0.00452	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	1.26e-05	0.00438	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCL5—metabolic syndrome X	1.26e-05	0.00435	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	1.24e-05	0.00428	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—MTNR1B—metabolic syndrome X	1.19e-05	0.00412	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—metabolic syndrome X	1.14e-05	0.00394	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	1.14e-05	0.00394	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—HTR2C—metabolic syndrome X	1.07e-05	0.00371	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—AGT—metabolic syndrome X	1.05e-05	0.00364	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR2C—metabolic syndrome X	1.05e-05	0.00363	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR2C—metabolic syndrome X	1.02e-05	0.00353	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—GHRL—metabolic syndrome X	1.02e-05	0.00352	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—GHRL—metabolic syndrome X	9.93e-06	0.00344	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	9.79e-06	0.00339	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—GHRL—metabolic syndrome X	9.67e-06	0.00335	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CNR1—metabolic syndrome X	9.62e-06	0.00333	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	9.57e-06	0.00332	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CNR1—metabolic syndrome X	9.41e-06	0.00326	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HTR2C—metabolic syndrome X	9.26e-06	0.00321	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CNR1—metabolic syndrome X	9.16e-06	0.00317	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	8.83e-06	0.00306	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—GHRL—metabolic syndrome X	8.78e-06	0.00304	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCL2—metabolic syndrome X	8.65e-06	0.003	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CNR1—metabolic syndrome X	8.31e-06	0.00288	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	8.19e-06	0.00284	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	8.01e-06	0.00278	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HDAC3—metabolic syndrome X	7.86e-06	0.00272	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	7.85e-06	0.00272	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	7.77e-06	0.00269	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	7.6e-06	0.00263	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	7.53e-06	0.00261	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL5—metabolic syndrome X	7.45e-06	0.00258	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL5—metabolic syndrome X	7.29e-06	0.00253	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCL5—metabolic syndrome X	7.1e-06	0.00246	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—MTNR1B—metabolic syndrome X	7.06e-06	0.00245	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MTNR1B—metabolic syndrome X	7.02e-06	0.00243	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—MTNR1B—metabolic syndrome X	6.9e-06	0.00239	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—RBP4—metabolic syndrome X	6.84e-06	0.00237	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TRIB3—metabolic syndrome X	6.84e-06	0.00237	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	6.74e-06	0.00234	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	6.6e-06	0.00229	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL5—metabolic syndrome X	6.44e-06	0.00223	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—PLA2G4A—metabolic syndrome X	6.42e-06	0.00222	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—AGT—metabolic syndrome X	6.23e-06	0.00216	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	6.22e-06	0.00215	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—AGT—metabolic syndrome X	6.1e-06	0.00211	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOC3—metabolic syndrome X	6.06e-06	0.0021	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2C—metabolic syndrome X	6.05e-06	0.0021	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	6.05e-06	0.0021	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—AGT—metabolic syndrome X	5.94e-06	0.00206	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2C—metabolic syndrome X	5.92e-06	0.00205	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	5.8e-06	0.00201	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—GHRL—metabolic syndrome X	5.74e-06	0.00199	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—GHRL—metabolic syndrome X	5.61e-06	0.00195	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2C—metabolic syndrome X	5.5e-06	0.0019	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2C—metabolic syndrome X	5.47e-06	0.0019	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CNR1—metabolic syndrome X	5.43e-06	0.00188	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—AGT—metabolic syndrome X	5.39e-06	0.00187	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2C—metabolic syndrome X	5.38e-06	0.00186	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CNR1—metabolic syndrome X	5.32e-06	0.00184	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CYBA—metabolic syndrome X	5.3e-06	0.00184	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—GHRL—metabolic syndrome X	5.21e-06	0.00181	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GHRL—metabolic syndrome X	5.19e-06	0.0018	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL2—metabolic syndrome X	5.13e-06	0.00178	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	5.12e-06	0.00177	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—GHRL—metabolic syndrome X	5.1e-06	0.00177	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL2—metabolic syndrome X	5.02e-06	0.00174	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	4.99e-06	0.00173	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CNR1—metabolic syndrome X	4.94e-06	0.00171	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—FMO3—metabolic syndrome X	4.93e-06	0.00171	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CNR1—metabolic syndrome X	4.91e-06	0.0017	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CNR1—metabolic syndrome X	4.83e-06	0.00167	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	4.81e-06	0.00167	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HDAC3—metabolic syndrome X	4.66e-06	0.00162	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	4.64e-06	0.00161	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HDAC3—metabolic syndrome X	4.56e-06	0.00158	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL2—metabolic syndrome X	4.44e-06	0.00154	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	4.4e-06	0.00152	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—EPHX2—metabolic syndrome X	4.4e-06	0.00152	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	4.24e-06	0.00147	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCL5—metabolic syndrome X	4.21e-06	0.00146	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MTNR1B—metabolic syndrome X	4.17e-06	0.00144	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—G6PC2—metabolic syndrome X	4.13e-06	0.00143	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCL5—metabolic syndrome X	4.12e-06	0.00143	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MTNR1B—metabolic syndrome X	4.08e-06	0.00141	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TRIB3—metabolic syndrome X	4.06e-06	0.00141	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RBP4—metabolic syndrome X	4.06e-06	0.00141	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF2—metabolic syndrome X	4.02e-06	0.00139	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TRIB3—metabolic syndrome X	3.97e-06	0.00138	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RBP4—metabolic syndrome X	3.97e-06	0.00138	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOB—metabolic syndrome X	3.9e-06	0.00135	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL5—metabolic syndrome X	3.83e-06	0.00133	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	3.81e-06	0.00132	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL5—metabolic syndrome X	3.81e-06	0.00132	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PLA2G4A—metabolic syndrome X	3.79e-06	0.00131	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL5—metabolic syndrome X	3.74e-06	0.0013	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	3.74e-06	0.0013	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	3.73e-06	0.00129	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—LPL—metabolic syndrome X	3.72e-06	0.00129	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOC3—metabolic syndrome X	3.6e-06	0.00125	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AGT—metabolic syndrome X	3.52e-06	0.00122	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOC3—metabolic syndrome X	3.52e-06	0.00122	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—FABP4—metabolic syndrome X	3.52e-06	0.00122	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AGT—metabolic syndrome X	3.45e-06	0.00119	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	3.33e-06	0.00115	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2C—metabolic syndrome X	3.25e-06	0.00113	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AGT—metabolic syndrome X	3.2e-06	0.00111	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AGT—metabolic syndrome X	3.18e-06	0.0011	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2C—metabolic syndrome X	3.18e-06	0.0011	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CYBA—metabolic syndrome X	3.15e-06	0.00109	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AGT—metabolic syndrome X	3.13e-06	0.00108	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—LEP—metabolic syndrome X	3.12e-06	0.00108	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOE—metabolic syndrome X	3.12e-06	0.00108	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOA1—metabolic syndrome X	3.08e-06	0.00107	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GHRL—metabolic syndrome X	3.08e-06	0.00107	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CYBA—metabolic syndrome X	3.08e-06	0.00107	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	3.07e-06	0.00106	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	3.07e-06	0.00106	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GHRL—metabolic syndrome X	3.01e-06	0.00104	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—G6PD—metabolic syndrome X	2.97e-06	0.00103	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CNR1—metabolic syndrome X	2.92e-06	0.00101	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HDAC3—metabolic syndrome X	2.9e-06	0.001	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	2.86e-06	0.000992	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CNR1—metabolic syndrome X	2.85e-06	0.000988	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GCKR—metabolic syndrome X	2.83e-06	0.000982	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LPA—metabolic syndrome X	2.83e-06	0.000982	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IRS1—metabolic syndrome X	2.78e-06	0.000965	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	2.74e-06	0.000951	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOA5—metabolic syndrome X	2.72e-06	0.000941	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—INS—metabolic syndrome X	2.67e-06	0.000924	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL2—metabolic syndrome X	2.64e-06	0.000913	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL2—metabolic syndrome X	2.62e-06	0.000909	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	2.59e-06	0.000898	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF1—metabolic syndrome X	2.58e-06	0.000893	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL2—metabolic syndrome X	2.58e-06	0.000893	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TRIB3—metabolic syndrome X	2.53e-06	0.000875	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SERPINE1—metabolic syndrome X	2.45e-06	0.000848	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	2.43e-06	0.000842	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF2—metabolic syndrome X	2.38e-06	0.000826	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NOS3—metabolic syndrome X	2.34e-06	0.00081	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF2—metabolic syndrome X	2.33e-06	0.000808	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOB—metabolic syndrome X	2.31e-06	0.000802	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NAMPT—metabolic syndrome X	2.27e-06	0.000785	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOB—metabolic syndrome X	2.26e-06	0.000784	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL5—metabolic syndrome X	2.26e-06	0.000783	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LIPC—metabolic syndrome X	2.25e-06	0.00078	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GCK—metabolic syndrome X	2.25e-06	0.00078	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.25e-06	0.00078	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOC3—metabolic syndrome X	2.24e-06	0.000775	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL5—metabolic syndrome X	2.21e-06	0.000766	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LPL—metabolic syndrome X	2.21e-06	0.000766	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.2e-06	0.000763	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CETP—metabolic syndrome X	2.17e-06	0.000753	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LPL—metabolic syndrome X	2.16e-06	0.000749	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	2.13e-06	0.000739	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SCARB1—metabolic syndrome X	2.08e-06	0.000721	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SREBF1—metabolic syndrome X	2.02e-06	0.0007	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—AKT1—metabolic syndrome X	2e-06	0.000694	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL6—metabolic syndrome X	1.97e-06	0.000683	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HMGCR—metabolic syndrome X	1.96e-06	0.000681	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GOT2—metabolic syndrome X	1.96e-06	0.000681	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.93e-06	0.000667	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AGT—metabolic syndrome X	1.89e-06	0.000655	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOE—metabolic syndrome X	1.85e-06	0.000642	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LEP—metabolic syndrome X	1.85e-06	0.000642	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AGT—metabolic syndrome X	1.85e-06	0.000641	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOA1—metabolic syndrome X	1.83e-06	0.000634	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—AKT1—metabolic syndrome X	1.82e-06	0.00063	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOE—metabolic syndrome X	1.81e-06	0.000628	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LEP—metabolic syndrome X	1.81e-06	0.000628	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOA1—metabolic syndrome X	1.79e-06	0.000621	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ABCA1—metabolic syndrome X	1.75e-06	0.000607	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	1.75e-06	0.000607	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GOT1—metabolic syndrome X	1.7e-06	0.000587	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GGT1—metabolic syndrome X	1.7e-06	0.000587	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IRS1—metabolic syndrome X	1.65e-06	0.000573	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IRS1—metabolic syndrome X	1.62e-06	0.00056	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—INS—metabolic syndrome X	1.58e-06	0.000548	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL2—metabolic syndrome X	1.56e-06	0.000539	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—INS—metabolic syndrome X	1.55e-06	0.000536	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TGFB1—metabolic syndrome X	1.55e-06	0.000536	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	1.53e-06	0.00053	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	1.52e-06	0.000528	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	1.5e-06	0.000519	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.45e-06	0.000504	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOB—metabolic syndrome X	1.44e-06	0.000499	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.42e-06	0.000493	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.4e-06	0.000485	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	1.39e-06	0.000481	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LPL—metabolic syndrome X	1.37e-06	0.000476	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	1.36e-06	0.00047	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CD36—metabolic syndrome X	1.31e-06	0.000452	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.21e-06	0.00042	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.19e-06	0.000412	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AGT—metabolic syndrome X	1.18e-06	0.000407	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	1.17e-06	0.000406	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6—metabolic syndrome X	1.16e-06	0.000404	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	1.16e-06	0.000403	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOE—metabolic syndrome X	1.15e-06	0.000399	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	1.14e-06	0.000397	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.14e-06	0.000394	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	1.08e-06	0.000374	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AKT1—metabolic syndrome X	1.07e-06	0.000372	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	1.06e-06	0.000366	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARG—metabolic syndrome X	1e-06	0.000348	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—INS—metabolic syndrome X	9.84e-07	0.000341	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	9.17e-07	0.000318	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALB—metabolic syndrome X	9.02e-07	0.000312	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	8.97e-07	0.000311	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NOS3—metabolic syndrome X	8.63e-07	0.000299	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS2—metabolic syndrome X	7.89e-07	0.000273	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	6.91e-07	0.00024	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	6.76e-07	0.000234	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	6.38e-07	0.000221	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	6.24e-07	0.000216	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AKT1—metabolic syndrome X	3.97e-07	0.000137	CbGpPWpGaD
